The role of splenectomy in autoimmune hematological disorders: Outdated or still worth considering?

Blood Rev. 2017 May;31(3):159-172. doi: 10.1016/j.blre.2017.01.001. Epub 2017 Jan 4.

¹ KU Leuven - University of Leuven, Department of General Internal Medicine, University Hospitals Leuven, B-3000, Leuven, Belgium. Electronic address: judith.sys@student.kuleuven.be.
² Department of Hematology, Barts and The London School of Medicine and Dentistry, Whitechapel, London, UK. Electronic address: a.b.provan@qmul.ac.uk.
³ Department of Hematology, University Hospital Ghent, B-9000, Ghent, Belgium. Electronic address: alexander.schauwvlieghe@ugent.be.
⁴ KU Leuven - University of Leuven, Department of Microbiology and Immunology, Laboratory for Clinical Infectious and Inflammatory Disorders, University Hospitals Leuven, Department of General Internal Medicine, B-3000, Leuven, Belgium. Electronic address: steven.vanderschueren@uzleuven.be.
⁵ KU Leuven - University of Leuven, Department of Oncology, Laboratory for Experimental Hematology, University Hospitals Leuven, Department of Hematology, B-3000, Leuven, Belgium. Electronic address: daan.dierickx@uzleuven.be.

No abstract available

Keywords: Autoimmune hemolytic anemia; Immune thrombocytopenia; Second-line treatment; Splenectomy; Thrombotic thrombocytopenic purpura.

Publication types